本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Terns Pharmaceuticals, Inc.

2.78
-0.1200-4.14%
盘后2.800.0200+0.72%19:46 EDT
成交量:86.66万
成交额:245.06万
市值:2.43亿
市盈率:-2.58
高:2.98
开:2.89
低:2.73
收:2.90
数据加载中...
2023/03/02

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/08

SEC问询函

CORRESP [Cover] - Correspondence
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/08

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/05

重要事件披露

8-K - Current report
2023/01/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/12/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/28

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/12/23

重要事件披露

8-K - Current report
2022/12/23

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/11/09

重要事件披露

8-K - Current report
2022/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans